ANTX - Latest News
AN2 Therapeutics, Inc. (ANTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $128.0M. Beta to the broader market is -0.99.
The article list below shows the most recent ANTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ANTX Headlines
The Healthcare M&A Wave
forbes.com - Jun 17, 2026
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe
AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease
businesswire.com - Jun 4, 2026
MENLO PARK, Calif. --(BUSINESS WIRE)--AN2 Therapeutics, Inc.
AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
businesswire.com - May 21, 2026
MENLO PARK, Calif. --(BUSINESS WIRE)--AN2 Therapeutics, Inc.
AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights
businesswire.com - May 11, 2026
MENLO PARK, Calif. --(BUSINESS WIRE)--AN2 Therapeutics, Inc.
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
businesswire.com - May 7, 2026
MENLO PARK, Calif. --(BUSINESS WIRE)--AN2 Therapeutics, Inc.
How News Affects ANTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ANTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ANTX news questions
- What is the latest ANTX news headline?
- The most recent ANTX headline (Jun 17, 2026) is "The Healthcare M&A Wave". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ANTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ANTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ANTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.